🔎 Trials Near Me

Hjem › Akut bifenoypisk leukemi › Texas › Dallas

Kliniske studier for Akut bifenoypisk leukemi i Dallas, TX

6 studier for Akut bifenoypisk leukemi søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekruttererFase 2
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
365 Days · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekruttererFase 3
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
365 Days – 25 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekruttererFase 1/2
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RekruttererFase 1
  • UT Southwestern/Simmons Cancer Center, Dallas
Alder 1 til 30 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06177067

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RekruttererFase 1/2
  • University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Alder 12 til 95 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekruttererFase 1
  • University of Texas, Southwestern, Dallas
Alder 1 til 21 · Alle kjønn · Oppdatert 6. des. 2024 · NCT05476770

Akut bifenoypisk leukemi-studier i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.